7 Reasons to Be Wary of Financial Advice from Almost Anyone
Groupon's New 'Snap' App Gets You Cash Back on Groceries
Toxic Chemicals Taint Many Halloween Costumes, Products
Week's Winners and Losers: Tough Sell for Some Gadgets
Johnson & Johnson Launches Offer for Crucell
Giant drugmaker Johnson & Johnson has agreed to buy Dutch vaccine maker Crucell. The deal will give J&J a bigger piece of the vaccine market and better access to emerging markets.
Still in hot water over its "phantom recall" of a Motrin product, Johnson & Johnson looks to expand its share of the vaccine market with purchase of Dutch pharma company Crucell.
Novavax (NVAX) shares soared some 10 percent today after the small clinical-stage biotechnology company announced positive preclinical results for...